miR-935 promotes gastric cancer cell proliferation by targeting SOX7 - 02/04/16
pages | 6 |
Iconographies | 5 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | miR-935 is upregulated in gastric cancer tissues and cells. |
• | miR-935 overexpression promotes cell proliferation and tumorigenesis in MKN28 cells. Knockdown of miR-935 inhibits cell proliferation and tumorigenesis. |
• | Tumor suppressor SOX7 is the target of miR-935. |
• | Inhibition of miR-935 and SOX7 promotes promotes cell proliferation and tumorigenesis in MKN28 cells. |
Abstract |
Gastric cancer is the most common cancer in the world, miRNAs have been demonstrated to play critical role in the development and progression of gastric cancer, such as miR-7, miR-217 and miR-335. Here, we found miR-935 was upregulated in gastric cancer tissues and cells. Overexpression of miR-935 promoted cell proliferation and tumorigenesis in vitro determined by MTT analysis, colony formation analysis, BrdU cell proliferation analysis and soft agar growth analysis, knockdown of miR-935 reduced these effects. Tumor suppressor sex-determining region Y-box 7 (SOX7) was the direct target of miR-935, overexpression of miR-935 inhibited SOX7 expression, but promoted the levels CCND1 and C-MYC which promotes cell proliferation and tumorigenesis, knockdown of miR-935 increased SOX7 level, and inhibited CCND1 and C-MYC expression. Synchronous knockdown of miR-935 and SOX7 promoted cell proliferation and tumorigenesis in vitro, confirming miR-935 regulated gastric cancer cell proliferation by inhibiting SOX7. In summary, we found miR-935 contributed to cell proliferation of gastric cancer through targeting SOX7.
Le texte complet de cet article est disponible en PDF.Keywords : Gastric cancer, miR-935, SOX7, Cell proliferation
Plan
Vol 79
P. 153-158 - avril 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?